🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cidara Therapeutics, Inc.

CDTX Healthcare
$221.38 +$0.06 (0.03%)
Market Cap: $6.97 B
Gurus Holding
9
Popularity Rank
#706
% of Shares Held
6.28%
Net Activity (Q4 2025)
-$111.66 M

Guru Ownership Trend

Guru Analysis for Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics, Inc. (CDTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $437.9 M.

Top institutional holders include Jefferies Group and Lee Ainslie.

Institutional sentiment is currently Bearish. This is evidenced by a $111.66 M net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 264.5%. Conversely, Steven Cohen reduced exposure by 84.2%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$181.69 M
Total Buy Value
New Buys 3
Additions 5
-$293.36 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
8

FAQs for Cidara Therapeutics, Inc. (CDTX)

Major holders include Jefferies Group ($169.32 M), Lee Ainslie ($100.72 M), George Soros ($60.74 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 1.98 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $111.66 M, with 8 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CDTX. The total reported sell value was $293.36 M.

Yes, 3 managers opened new positions in CDTX, and 5 increased their existing holdings. The total reported buy value was $181.69 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.87% Add 110.0% 766,520 $169.32 M Q4 2025
1.08% Add 9.2% 455,978 $100.72 M Q4 2025
0.70% New Buy 275,000 $60.74 M Q4 2025
0.06% Reduce -84.2% 250,000 $55.22 M Q4 2025
0.04% Add 6.0% 110,560 $24.42 M Q4 2025
0.24% New Buy 49,495 $10.93 M Q4 2025
0.02% Add 196.5% 44,307 $9.79 M Q4 2025
0.00% Add 264.5% 13,699 $3.03 M Q4 2025
0.03% New Buy 12,500 $2.76 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form